Diabetes Screening Reminder for Women With Prior Gestational Diabetes A Randomized Controlled Trial

被引:21
|
作者
Zera, Chloe A.
Bates, David W.
Stuebe, Alison M.
Ecker, Jeffrey L.
Seely, Ellen W.
机构
[1] Brigham & Womens Hosp, Div Maternal Fetal Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Internal Med, Boston, MA 02115 USA
[4] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[5] Massachusetts Gen Hosp, Div Maternal Fetal Med, Dept Obstet & Gynecol, Boston, MA 02114 USA
[6] Univ N Carolina, Dept Obstet & Gynecol, Div Maternal Fetal Med, Sch Med, Chapel Hill, NC 27599 USA
来源
OBSTETRICS AND GYNECOLOGY | 2015年 / 126卷 / 01期
基金
美国国家卫生研究院;
关键词
MELLITUS; HISTORY;
D O I
10.1097/AOG.0000000000000883
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To evaluate whether an electronic health record (EHR) reminder improves rates of screening for type 2 diabetes in women with prior gestational diabetes. METHODS: We randomly allocated primary care providers (by clinic site) to a reminder for type 2 diabetes screening within the EHR or to usual care. Women with previous gestational diabetes mellitus were identified through an automated search of laboratory results and the problem list. We compared rates of screening during the study period (2010-2012) in women at intervention sites with those at control sites. With a sample size of 850 participants, we had 80% power to detect a 15% difference in screening rates. RESULTS: We included 847 individuals seen at a participating clinic during the study period, of whom 471 were at a reminder clinic and 376 were at a control clinic. A similar proportion of women were screened for type 2 diabetes in both groups (n=265, 56.3% of the reminder group compared with n=206, 54.8% of the control group, P=.67; adjusted odds ratio [OR] 1.04, 95% confidence interval [CI] 0.79-1.38). Patient characteristics associated with risk for diabetes including body mass index (adjusted OR per kg/m(2) 1.05, 95% CI 1.01-1.08) and race (adjusted OR for nonwhite race 2.14, 95% CI 1.57-2.92) were significantly associated with screening. CONCLUSION: A simple EHR reminder did not increase the rate of diabetes screening in women with prior gestational diabetes mellitus.
引用
收藏
页码:109 / 114
页数:6
相关论文
共 50 条
  • [1] A Cluster Randomized, Controlled Trial of a Diabetes Screening Reminder for Women with a History of Gestational Diabetes
    Zera, Chloe
    Bates, David W.
    Stuebe, Alison
    Ecker, Jeffrey
    Seely, Ellen W.
    DIABETES, 2014, 63 : A95 - A95
  • [2] A reminder system for postpartum diabetes screening after gestational diabetes: a randomized clinical trial
    Khalifeh, Adeeb
    Khosla, Jayasree
    Cantor, Eva
    Quist-Nelson, Johanna
    Saccone, Gabriele
    Tumas, Jordyn
    Berghella, Vincenzo
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2022, 35 (25): : 7518 - 7522
  • [3] Early gestational diabetes screening in obese women: a randomized controlled trial
    Harper, Lorie M.
    Jauk, Victoria
    Longo, Sherri
    Biggio, Joseph R.
    Szychowski, Jeff M.
    Tita, Alan T.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (05)
  • [4] Early gestational diabetes screening in obese women: a randomized controlled trial
    Harper, Lorie M.
    Jauk, Victoria C.
    Longo, Sherri
    Biggio, Joseph R.
    Szychowski, Jeff M.
    Tita, Alan T.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 220 (01) : S5 - S6
  • [5] A physician reminder to improve postpartum diabetes screening in women with gestational diabetes mellitus
    Lega, Iliana C.
    McLaughlin, Heather
    Coroneos, Marie
    Handley-Derry, Frances
    Donovan, Nicola
    Lipscombe, Lorraine L.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 95 (03) : 352 - 357
  • [6] TRIPOD (TRoglitazone in the Prevention of Diabetes): A randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus
    Azen, SP
    Peters, RK
    Berkowitz, K
    Kjos, S
    Xiang, A
    Buchanan, TA
    CONTROLLED CLINICAL TRIALS, 1998, 19 (02): : 217 - 231
  • [7] Do postal reminders increase postpartum screening of diabetes mellitus in women with gestational diabetes mellitus? A randomized controlled trial
    Clark, Heather D.
    Graham, Ian D.
    Karovitch, Alan
    Keely, Erin J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 634.e1 - 634.e7
  • [8] Effect of an electronic reminder of follow-up screening after pregnancy complicated by gestational diabetes mellitus: a randomized controlled trial
    Jane Hyldgaard Nielsen
    Kirsten Fonager
    Jette Kolding Kristensen
    Charlotte Overgaard
    BMC Public Health, 23
  • [9] Effect of an electronic reminder of follow-up screening after pregnancy complicated by gestational diabetes mellitus: a randomized controlled trial
    Nielsen, Jane Hyldgaard
    Fonager, Kirsten
    Kristensen, Jette Kolding
    Overgaard, Charlotte
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [10] Intrapartum Glucose Management in Women With Gestational Diabetes Mellitus A Randomized Controlled Trial
    Hamel, Maureen S.
    Kanno, Lindsey M.
    Has, Phinnara
    Beninati, Michael J.
    Rouse, Dwight J.
    Werner, Erika F.
    OBSTETRICS AND GYNECOLOGY, 2019, 133 (06): : 1171 - 1177